APYX MEDICAL CORP (APYX:NASDAQ)
$3.98 0.04 (1.0152%)
Analysed APYX MEDICAL CORP (APYX:NASDAQ) News Sources
Why The Apyx Medical (APYX) Story Is Shifting With New Guidance And GLP-1 Demand
06-04-2026
yahoo.com
Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year?
02-04-2026
yahoo.com
Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
01-04-2026
yahoo.com
Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?
31-03-2026
yahoo.com
How The Apyx Medical (APYX) Story Is Evolving With New Growth Drivers And Profitability Goals
23-03-2026
yahoo.com
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?
17-03-2026
yahoo.com
Apyx Medical Calls AYON a “Game Changer” at Citizens Conference, Targets Profitability in 2025
12-03-2026
marketbeat.com
Apyx Medical Corp (APYX) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
10-03-2026
yahoo.com
Apyx Medical Q4 Earnings Call Highlights
10-03-2026
marketbeat.com
Apyx: Q4 Earnings Snapshot
10-03-2026
yahoo.com
What is the current price of APYX MEDICAL CORP (APYX:NASDAQ)?
The current price of APYX MEDICAL CORP (APYX:NASDAQ) is $3.98.
APYX MEDICAL CORP (APYX:NASDAQ) absolute price change since previous trading day?
The absolute price change of APYX MEDICAL CORP (APYX:NASDAQ) since the previous trading day is $0.04.
APYX MEDICAL CORP (APYX:NASDAQ) percentage price change since previous trading day?
The percentage price change of APYX MEDICAL CORP (APYX:NASDAQ) since the previous trading day is 1.0152%.
What is the most recent average sentiment score for APYX MEDICAL CORP (APYX:NASDAQ)?
The most recent average sentiment score for APYX MEDICAL CORP (APYX:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for APYX MEDICAL CORP (APYX:NASDAQ)?
The most recent sentiment for APYX MEDICAL CORP (APYX:NASDAQ) is .
SEC-8K** Filing Available For APYX MEDICAL CORP (APYX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.